What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders (Straub et al.)

Published: Nov 28, 2022
Journal of Medicinal Chemistry

~

(Preproof) Considerations in assessing the abuse potential of psychedelics during drug development (Calderon et al.)

Available Online: Nov 28, 2022
Neuropharmacology